These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1784070

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of severe infection in patients with hematological disorders by cefminox. Tokai Infection Study Group].
    Okumura M, Ohno R, Mitomo Y, Hirano M, Shirakawa S, Yoshikawa S, Kobayashi M, Yamada K.
    Jpn J Antibiot; 1985 Jun; 38(6):1619-24. PubMed ID: 3930807
    [Abstract] [Full Text] [Related]

  • 6. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S, Tsuda S, Taniwaki M, Horiike S, Ariyama Y, Hirakawa K, Ueda Y, Kaneko H, Nakao M, Kashima K.
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S, Tsuda S, Nakagawa H, Nishigaki H, Okuda T, Taniwaki M, Misawa S, Takino T, Abe T.
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [Abstract] [Full Text] [Related]

  • 8. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K.
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of cefminox on severe infections accompanying hematological diseases].
    Saito T, Urabe A, Takaku F, Kano Y, Sakamoto S, Miura Y, Dan K, Nomura T, Totsuka K, Mizoguchi H.
    Jpn J Antibiot; 1985 Jan; 38(1):114-20. PubMed ID: 3921742
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
    Kageyama T, Ohyabu H, Masaoka T, Shibata H, Nagai K, Kitani T, Horiuchi A, Kawagoe H, Yasunaga K, Yonezawa T.
    Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
    [Abstract] [Full Text] [Related]

  • 12. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T, Tamura K, Okamoto K, Kawada E, Murayama K, Maehara T, Sadakata H, Tamura J, Sawamura M, Morita K.
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of ceftazidime monotherapy for infections complicated with hematological disorders].
    Kuzuyama Y, Tsuda S, Seriu T, Nakai H, Murakami T, Takashima T, Takahashi Y, Tanaka S, Nakagawa H, Nishigaki H.
    Jpn J Antibiot; 1992 May; 45(5):523-9. PubMed ID: 1512938
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    Yamane T, Tanaka K, Hasuike T, Hirai M, Misu K, Ota K, Ohira H, Nakao Y, Yasui Y, Inoue T.
    Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
    Yamane T, Nakao Y, Yasui Y, Ota K, Ohira H, Inoue T, Furukawa Y, Hiyoshi M, Sasaki A, Kishida T.
    Jpn J Antibiot; 1990 Nov; 43(11):1843-9. PubMed ID: 2287053
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y, Iwai T, Tamura A, Nakazawa N, Ueda Y, Kaneko H, Horiike S, Yokota S, Taniwaki M, Kashima K, Misawa S, Tsuda S, Ohgawara Y.
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.